|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Discontinued operations, net of tax | |||||
| Income (loss) from continuing operations | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Goodwill impairment | |||||
| Loss on repayment of loans | |||||
| Deferred taxes | |||||
| Stock-based compensation | |||||
| Provision for losses on trade accounts receivable | |||||
| Impairment of Long-Lived Assets to be Disposed of | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| Trade accounts receivable | |||||
| Other current and long-term assets | |||||
| Trade accounts payable | |||||
| Other current and long-term liabilities | |||||
| Cash provided by operating activities of continuing operations | |||||
| Cash used in operating activities of discontinued operations | |||||
| Cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Proceeds from sale/maturity of other investments | |||||
| Purchases of other investments | |||||
| Investments in consolidated affiliates, net of cash acquired | |||||
| Investments in nonconsolidated affiliates and notes receivable | |||||
| Proceeds from the sale of investments in nonconsolidated affiliates | |||||
| (Payments) proceeds related to disposal of discontinued operations | |||||
| Proceeds from note receivable | |||||
| Other | |||||
| Cash used in investing activities of continuing operations | |||||
| Cash used in investing activities of discontinued operations | |||||
| Cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from Term Loans | |||||
| Repayments of Term Loans | |||||
| Repayments of debt | |||||
| Debt financing fees | |||||
| Proceeds from issuance of common stock and exercise of stock options | |||||
| Dividends to shareholders | |||||
| Employee taxes paid on restricted stock units recorded as treasury stock | |||||
| Payment of contingent consideration | |||||
| Repurchases of common stock | |||||
| Distributions to noncontrolling interests | |||||
| Cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the period for: | |||||
| Total | |||||
| Interest Paid, Excluding Capitalized Interest, Operating Activity | |||||
Loading...